These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8876709

  • 1. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H, Stein U, Aumüller G, Remberger K.
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [Abstract] [Full Text] [Related]

  • 2. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C, Lobaccaro JM, Lumbroso S, Lechevallier E, Mottet N, Gibelin B, Sultan C.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB.
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [Abstract] [Full Text] [Related]

  • 9. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
    Ji Q, Chang L, VanDenBerg D, Stanczyk FZ, Stolz A.
    Prostate; 2003 Mar 01; 54(4):275-89. PubMed ID: 12539226
    [Abstract] [Full Text] [Related]

  • 10. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.
    Titus MA, Gregory CW, Ford OH, Schell MJ, Maygarden SJ, Mohler JL.
    Clin Cancer Res; 2005 Jun 15; 11(12):4365-71. PubMed ID: 15958619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS, Imperato-McGinley JL.
    Ann N Y Acad Sci; 2009 Feb 15; 1155():43-56. PubMed ID: 19250191
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
    Torres JM, Ruiz E, Ortega E.
    Prostate; 2003 Jun 15; 56(1):74-9. PubMed ID: 12746849
    [Abstract] [Full Text] [Related]

  • 17. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
    Ye L, Zhang Y, Fang Z.
    Zhonghua Yi Xue Za Zhi; 2001 Dec 25; 81(24):1504-7. PubMed ID: 16200776
    [Abstract] [Full Text] [Related]

  • 18. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y.
    Zhonghua Yi Xue Za Zhi; 1991 May 25; 71(5):263-5, 20. PubMed ID: 1713809
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.
    Oliveira OL, Koff WJ, Muraro F, Santos EB, Gomes Soares DF, Trindade VM.
    Clin Chim Acta; 2008 May 25; 391(1-2):36-40. PubMed ID: 18328817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.